Skip to main content

Cisatracurium Besylate Injection Shortage

Last Updated: September 9, 2016
Status: Resolved

Reason for the Shortage
    • Fresenius Kabi had cisatracurium besylate injection on shortage due to increased demand.
Available Products
    • Nimbex injection, AbbVie, 10 mg/mL, 20 mL vial, 10 count, NDC 00074-4382-20
    • Nimbex injection, AbbVie, 2 mg/mL, 10 mL vial, 10 count, NDC 00074-4380-10
    • Nimbex injection, AbbVie, 2 mg/mL, 5 mL vial, 10 count, NDC 00074-4378-05
    • Cisatracurium besylate injection, Fresenius Kabi, 10 mg/mL, 20 mL vial, 10 count, NDC 63323-0418-20
    • Cisatracurium besylate injection, Fresenius Kabi, 2 mg/mL, 10 mL vial, 10 count, NDC 63323-0417-10
    • Cisatracurium besylate injection, Fresenius Kabi, 2 mg/mL, 5 mL vial, 10 count, NDC 63323-0416-05
    • Cisatracurium besylate injection, Sandoz, 10 mg/mL, 20 mL vial, 10 count, NDC 00781-3153-95
    • Cisatracurium besylate injection, Sandoz, 2 mg/mL, 10 mL vial, 10 count, NDC 00781-3152-95
    • Cisatracurium besylate injection, Sandoz, 2 mg/mL, 5 mL vial, 10 count, NDC 00781-3150-95

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated September 9, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 14, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer